Leigh Ann Humphries, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fertilization in Vitro | 5 | 2024 | 1301 | 1.230 |
Why?
|
Pregnancy Rate | 3 | 2023 | 654 | 0.960 |
Why?
|
Birth Rate | 2 | 2023 | 168 | 0.790 |
Why?
|
Oocyte Donation | 1 | 2019 | 52 | 0.630 |
Why?
|
Pregnancy Outcome | 2 | 2019 | 2969 | 0.530 |
Why?
|
Fundoplication | 1 | 2013 | 146 | 0.390 |
Why?
|
Vaccination | 1 | 2024 | 3431 | 0.380 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2013 | 545 | 0.350 |
Why?
|
Tumor Suppressor Proteins | 3 | 2020 | 2793 | 0.350 |
Why?
|
Neoplasm Proteins | 3 | 2020 | 3594 | 0.310 |
Why?
|
Infertility | 1 | 2015 | 655 | 0.310 |
Why?
|
Laparoscopy | 3 | 2024 | 2039 | 0.290 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2014 | 1642 | 0.250 |
Why?
|
Gastroesophageal Reflux | 1 | 2013 | 834 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2013 | 8613 | 0.180 |
Why?
|
Anastomosis, Surgical | 1 | 2024 | 992 | 0.170 |
Why?
|
Patient Satisfaction | 1 | 2013 | 3477 | 0.170 |
Why?
|
Uterus | 1 | 2024 | 660 | 0.170 |
Why?
|
Cystoscopy | 1 | 2020 | 128 | 0.170 |
Why?
|
Semen | 1 | 2022 | 351 | 0.170 |
Why?
|
Female Urogenital Diseases | 1 | 2020 | 57 | 0.170 |
Why?
|
STAT Transcription Factors | 2 | 2020 | 189 | 0.160 |
Why?
|
Vagina | 1 | 2024 | 849 | 0.150 |
Why?
|
Ureteral Obstruction | 1 | 2020 | 293 | 0.150 |
Why?
|
Malpractice | 1 | 2022 | 561 | 0.150 |
Why?
|
Transcription Factors | 2 | 2013 | 12128 | 0.130 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2532 | 0.120 |
Why?
|
Janus Kinases | 1 | 2015 | 253 | 0.110 |
Why?
|
Cyclopentanes | 1 | 2014 | 87 | 0.110 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2014 | 85 | 0.110 |
Why?
|
Eructation | 1 | 2013 | 6 | 0.110 |
Why?
|
Laser Therapy | 1 | 2020 | 1108 | 0.100 |
Why?
|
Barium Sulfate | 1 | 2013 | 180 | 0.100 |
Why?
|
Immunoglobulin Variable Region | 1 | 2013 | 419 | 0.100 |
Why?
|
Hernia, Hiatal | 1 | 2013 | 90 | 0.100 |
Why?
|
Endometriosis | 1 | 2020 | 869 | 0.100 |
Why?
|
Esophageal pH Monitoring | 1 | 2013 | 203 | 0.100 |
Why?
|
Gastroscopy | 1 | 2013 | 212 | 0.090 |
Why?
|
Interferons | 1 | 2015 | 714 | 0.090 |
Why?
|
Adenocarcinoma | 3 | 2014 | 6361 | 0.090 |
Why?
|
Membrane Proteins | 2 | 2020 | 7850 | 0.090 |
Why?
|
RNA, Neoplasm | 1 | 2013 | 744 | 0.090 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2013 | 647 | 0.090 |
Why?
|
Pancreatic Neoplasms | 3 | 2014 | 5454 | 0.090 |
Why?
|
Genes, Tumor Suppressor | 1 | 2015 | 1058 | 0.090 |
Why?
|
Abortion, Spontaneous | 1 | 2015 | 536 | 0.090 |
Why?
|
Postoperative Complications | 4 | 2024 | 15803 | 0.090 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 7840 | 0.090 |
Why?
|
Pancreaticoduodenectomy | 1 | 2012 | 515 | 0.080 |
Why?
|
Alternative Splicing | 1 | 2013 | 1102 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2013 | 1150 | 0.070 |
Why?
|
Pregnancy | 3 | 2023 | 30227 | 0.070 |
Why?
|
Stromal Cells | 1 | 2013 | 1332 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2013 | 5334 | 0.070 |
Why?
|
Physician's Role | 1 | 2014 | 925 | 0.070 |
Why?
|
Up-Regulation | 2 | 2013 | 4133 | 0.070 |
Why?
|
Deglutition Disorders | 1 | 2013 | 640 | 0.070 |
Why?
|
HCT116 Cells | 2 | 2020 | 399 | 0.070 |
Why?
|
Lymphoma, B-Cell | 1 | 2013 | 943 | 0.070 |
Why?
|
MicroRNAs | 2 | 2013 | 3787 | 0.070 |
Why?
|
Female | 12 | 2024 | 396158 | 0.060 |
Why?
|
NF-kappa B | 1 | 2014 | 2495 | 0.060 |
Why?
|
Adult | 6 | 2024 | 223106 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3423 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 2005 | 0.060 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2024 | 34 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2024 | 65199 | 0.050 |
Why?
|
Health Status Disparities | 1 | 2015 | 1877 | 0.050 |
Why?
|
Humans | 17 | 2024 | 766000 | 0.050 |
Why?
|
Mullerian Ducts | 1 | 2024 | 203 | 0.050 |
Why?
|
Reoperation | 1 | 2013 | 4308 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2014 | 17070 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18382 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5784 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2838 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2014 | 11202 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2825 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6943 | 0.050 |
Why?
|
Pyrimidines | 1 | 2014 | 3048 | 0.050 |
Why?
|
Chorionic Gonadotropin | 1 | 2023 | 457 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15882 | 0.050 |
Why?
|
Apoptosis | 2 | 2014 | 9507 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4783 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2024 | 1102 | 0.040 |
Why?
|
Recurrence | 1 | 2013 | 8494 | 0.040 |
Why?
|
Decision Making | 1 | 2014 | 3954 | 0.040 |
Why?
|
Live Birth | 1 | 2023 | 516 | 0.040 |
Why?
|
Contrast Media | 1 | 2013 | 5329 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2024 | 81542 | 0.040 |
Why?
|
DNA Methylation | 1 | 2013 | 4426 | 0.040 |
Why?
|
Leiomyoma | 1 | 2024 | 644 | 0.040 |
Why?
|
Congenital Abnormalities | 1 | 2024 | 703 | 0.040 |
Why?
|
Lasers, Gas | 1 | 2020 | 104 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 12772 | 0.040 |
Why?
|
Comorbidity | 1 | 2013 | 10577 | 0.040 |
Why?
|
Young Adult | 2 | 2024 | 59857 | 0.030 |
Why?
|
Informed Consent | 1 | 2022 | 1010 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2024 | 1425 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39233 | 0.030 |
Why?
|
Tissue Donors | 1 | 2024 | 2389 | 0.030 |
Why?
|
Organ Transplantation | 1 | 2024 | 1172 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2015 | 431 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2012 | 3604 | 0.030 |
Why?
|
Graft Survival | 1 | 2024 | 3904 | 0.030 |
Why?
|
Florida | 1 | 2014 | 416 | 0.030 |
Why?
|
United States | 2 | 2022 | 72916 | 0.020 |
Why?
|
Mice | 3 | 2014 | 81821 | 0.020 |
Why?
|
Middle Aged | 5 | 2024 | 223025 | 0.020 |
Why?
|
Exonucleases | 1 | 2011 | 42 | 0.020 |
Why?
|
Exoribonucleases | 1 | 2011 | 88 | 0.020 |
Why?
|
Algorithms | 1 | 2012 | 14065 | 0.020 |
Why?
|
Time Factors | 1 | 2013 | 40100 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13634 | 0.020 |
Why?
|
Tissue Culture Techniques | 1 | 2012 | 286 | 0.020 |
Why?
|
Adolescent | 1 | 2019 | 88808 | 0.020 |
Why?
|
14-3-3 Proteins | 1 | 2011 | 221 | 0.020 |
Why?
|
Sampling Studies | 1 | 2012 | 613 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2015 | 959 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1742 | 0.020 |
Why?
|
Probability | 1 | 2014 | 2475 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2011 | 697 | 0.020 |
Why?
|
Stents | 1 | 2020 | 3191 | 0.020 |
Why?
|
Aged | 4 | 2014 | 171161 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5739 | 0.020 |
Why?
|
Databases, Factual | 1 | 2022 | 8062 | 0.020 |
Why?
|
Animals | 3 | 2014 | 168775 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2011 | 1715 | 0.020 |
Why?
|
Colectomy | 1 | 2012 | 696 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5019 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2015 | 2864 | 0.020 |
Why?
|
Male | 5 | 2022 | 363855 | 0.020 |
Why?
|
Signal Transduction | 3 | 2015 | 23600 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21509 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3796 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2011 | 3089 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6057 | 0.010 |
Why?
|
Down-Regulation | 1 | 2012 | 2927 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5879 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2014 | 3722 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2011 | 4262 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8524 | 0.010 |
Why?
|
Risk Factors | 2 | 2024 | 74838 | 0.010 |
Why?
|
Trans-Activators | 1 | 2011 | 2849 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6506 | 0.010 |
Why?
|
Cause of Death | 1 | 2012 | 3712 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2011 | 2945 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2014 | 3942 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11035 | 0.010 |
Why?
|
Cell Movement | 1 | 2011 | 5194 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12530 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54797 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12821 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14644 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10431 | 0.010 |
Why?
|
Child | 1 | 2022 | 80567 | 0.010 |
Why?
|
Prognosis | 1 | 2014 | 29904 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2012 | 59493 | 0.000 |
Why?
|